A prospective randomised clinical study on evaluation of platelet‐rich fibrin versus zinc oxide eugenol in the management of alveolar osteitis. (31st August 2017)

• Record Type: Journal Article
• Authors: Hussain, I.; Singh, S.; Jain, H.; Kumar, S.; Anand, K.R.; Batool, N.; Saikia, J.
• Is Part Of: Oral surgery. Volume 11:Number 1(2018:Feb.)
• Page Start: 41
• Page End: 49
• Publication Date: 2017-08-31
• Subjects: alveolar osteitis -- platelet‐rich fibrin -- zinc oxide eugenol; Mouth -- Surgery -- Periodicals; 617.522059
• DOI: 10.1111/ors.12299
• Languages: English
• ISSNs: 1752-2471

Abstract

Abstract: Purpose: The aim of this study was to evaluate the efficacy of platelet‐rich fibrin (PRF) in the management of alveolar osteitis and further compare the results with those of zinc‐oxide Eugenol (ZOE). Materials and methods: A total of 40 patients with alveolar osteitis following extraction of mandibular molars were randomly divided into two groups on the basis of treatment, in which Group A patient's received PRF and Group B received ZOE as an obtundant dressing. Pain (VAS), degree of inflammation and number of exposed socket walls were noted and evaluated at 1st, 3rd, 5th and 7th post‐operative day. Results: Group A showed better and faster socket healing than Group B. However, symptomatic pain relief was faster in Group B than in Group A. Conclusion: PRF might be a treatment of choice in the management of alveolar osteitis.